There are 699 resources available
397MO - Tislelizumab (TIS) plus chemotherapy (CT) vs placebo (PBO) plus CT in HER2-negative advanced or metastatic gastric or gastro-esophageal junction adenocarcinoma (GC/GEJC): PD-L1 biomarker analysis from RATIONALE-305
Presenter: Markus Moehler
Session: Mini Oral session 3
Resources:
Abstract
Slides
Webcast
Invited discussant abstracts 395MO, 396MO and 397MO
Presenter: David Ilson
Session: Mini Oral session 3
Resources:
Slides
Webcast
Q&A and discussion
Session: Mini Oral session 3
Resources:
Webcast
Keynote lecture: Ten years of improvement in the treatment of liver cancer
Presenter: Stephen Chan
Session: ESMO GI 2024 Keynote and take-home messages
Resources:
Slides
Webcast
How to integrate patient perspectives in GI cancer management and research
Presenter: Zorana Maravic
Session: ESMO GI 2024 Keynote and take-home messages
Resources:
Slides
Webcast
Colorectal cancer
Presenter: Eric Van Cutsem
Session: ESMO GI 2024 Keynote and take-home messages
Resources:
Slides
Webcast
Hepatopancreaticobiliary cancer
Presenter: Teresa Macarulla Mercade
Session: ESMO GI 2024 Keynote and take-home messages
Resources:
Slides
Webcast
Upper GI cancers
Presenter: Michel Ducreux
Session: ESMO GI 2024 Keynote and take-home messages
Resources:
Slides
Webcast
Challenges for managing elderly patients with GI cancer
Presenter: Demetris Papamichael
Session: ESMO GI 2024 Keynote and take-home messages
Resources:
Slides
Webcast